Standard BioTools (LAB) and SomaLogic (SLGC) to Combine in All-Stock Merger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
October 4, 2023 8:00 AM EDTActivates Standard BioTools strategy to unlock value in underserved portion of $100 billion industry
Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights
Expands commercial reach with substantial cross-selling opportunities and complementary offerings
Generates estimated $80 million of annual cost synergies by 2026 and enhanced combined path to profitability1
Estimated combined cash of over $500 million at close2 creates industry-leading balance sheet to fund growth initiatives
Standard BioTools increases... More



